Nandini Verma

809 total citations
19 papers, 554 citations indexed

About

Nandini Verma is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nandini Verma has authored 19 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nandini Verma's work include HER2/EGFR in Cancer Research (3 papers), Phytochemistry and Bioactive Compounds (2 papers) and Natural product bioactivities and synthesis (2 papers). Nandini Verma is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Phytochemistry and Bioactive Compounds (2 papers) and Natural product bioactivities and synthesis (2 papers). Nandini Verma collaborates with scholars based in India, United States and Israel. Nandini Verma's co-authors include Sima Lev, Thomas Karn, Rakha H. Das, Rina Chakrabarti, JaiGopal Sharma, P. K. Srivastava, Michael Selitrennik, Gordon B. Mills, Ashish Saroha and Nishanth Ulhas Nair and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Nandini Verma

19 papers receiving 545 citations

Peers

Nandini Verma

ONCOL

PRM

IMMUN

Weixi Shen China

Miao Yu China

Tao Xin China

Wensheng Zhang China

Eun‐Sun Choi South Korea

Yajing Yang China

Yongqiang Chen China

Yi-Li Feng China

Keiko Shoji Japan

Shiwei Zhao China

Weixi Shen China

Nandini Verma

181 ×0.7

155 ×1.2

ONCOL

138 ×1.1

PRM

89 ×0.8

58 ×0.5

IMMUN

Citations per year, relative to Nandini Verma Nandini Verma (= 1×) peers Weixi Shen

Countries citing papers authored by Nandini Verma

Since Specialization

Citations

This map shows the geographic impact of Nandini Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nandini Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nandini Verma more than expected).

Fields of papers citing papers by Nandini Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nandini Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nandini Verma. The network helps show where Nandini Verma may publish in the future.

Co-authorship network of co-authors of Nandini Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Nandini Verma. A scholar is included among the top collaborators of Nandini Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nandini Verma. Nandini Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ferlita, Alessandro La, Mufaddal Kazi, Vikas Ostwal, et al.. (2025). Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas. Clinical Cancer Research. 31(7). 1359–1373. 4 indexed citations

Sahoo, Sarthak, et al.. (2025). EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI. Cancer Cell International. 25(1). 55–55. 2 indexed citations

Verma, Nandini, et al.. (2024). Anticandidal Efficacy of Green Synthesized Silver Nanoparticles Using Trans-Himalayan Plant Extracts Against Drug Resistant Clinical Isolates of Candida auris. Indian Journal of Microbiology. 64(4). 1912–1928. 4 indexed citations

Verma, Nandini, et al.. (2022). P013 Green synthesis of silver nanoparticles using Trillium govanianum and its antifungal potential against Candida auris. Medical Mycology. 60(Supplement_1). 1 indexed citations

McDonald, Jasmine A., Roshni Rao, Rajiv Janardhanan, et al.. (2021). Symposium report: breast cancer in India—trends, environmental exposures and clinical implications. Cancer Causes & Control. 32(6). 567–575. 15 indexed citations

Kumar, Rakesh, Bijesh George, Marcia R. Campbell, et al.. (2020). HER family in cancer progression: From discovery to 2020 and beyond. Advances in cancer research. 147. 109–160. 39 indexed citations

Verma, Nandini, Yaron Vinik, Ashish Saroha, et al.. (2020). Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Science Advances. 6(34). 128 indexed citations

Shin, Sung‐Young, et al.. (2018). Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer. PLoS Computational Biology. 14(6). e1006192–e1006192. 24 indexed citations

Kedan, Amir, Nandini Verma, Ashish Saroha, et al.. (2018). PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death and Disease. 9(10). 985–985. 28 indexed citations

10.

Verma, Nandini, Charu Kothari, Amir Kedan, et al.. (2016). Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4–NDRG1 Axis. Cancer Research. 77(1). 86–99. 61 indexed citations

11.

Verma, Nandini, Omer Keinan, Michael Selitrennik, et al.. (2015). PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition. Nature Communications. 6(1). 6064–6064. 63 indexed citations

12.

Gupta, Deepika, Nandini Verma, Hasi R. Das, & Rajinder K. Gupta. (2014). Evaluation of anti-inflammatory activity of Dracaena cinnabari Balf. f. resin. Indian Journal of Natural Products and Resources. 5(3). 215–222. 5 indexed citations

13.

Chakrabarti, Rina, P. K. Srivastava, Nandini Verma, & JaiGopal Sharma. (2014). Effect of seeds of Achyranthes aspera on the immune responses and expression of some immune-related genes in carp Catla catla. Fish & Shellfish Immunology. 41(1). 64–69. 69 indexed citations

14.

Verma, Nandini, Rina Chakrabarti, Rakha H. Das, & Hemant K. Gautam. (2012). Anti-Inflammatory Effects of Shea Butter through Inhibition of Inos, Cox-2, and Cytokines via the Nf-Kb Pathway in Lps-Activated J774 Macrophage Cells. Journal of Complementary and Integrative Medicine. 9(1). 1–11. 28 indexed citations

15.

Verma, Nandini, Subhash Tripathi, Indrajit Chaudhury, Hasi R. Das, & Rakha H. Das. (2010). iNOS-TARGETED 10-23 DNAZYME REDUCES LPS-INDUCED SYSTEMIC INFLAMMATION AND MORTALITY IN MICE. Shock. 33(5). 493–499. 12 indexed citations

16.

Verma, Nandini, Indrajit Chaudhury, Deepak Kumar, & Rakha H. Das. (2009). Silencing of TNF‐α receptors coordinately suppresses TNF‐α expression through NF‐κB activation blockade in THP‐1 macrophage. FEBS Letters. 583(17). 2968–2974. 9 indexed citations

17.

Verma, Nandini, Subhash Tripathi, Debasis Sahu, Hasi R. Das, & Rakha H. Das. (2009). Evaluation of inhibitory activities of plant extracts on production of LPS-stimulated pro-inflammatory mediators in J774 murine macrophages. Molecular and Cellular Biochemistry. 336(1-2). 127–135. 54 indexed citations

18.

Verma, Nandini, et al.. (2009). 9-cis-canthaxanthin exhibits higher pro-apoptotic activity than all-trans-canthaxanthin isomer in THP-1 macrophage cells. Free Radical Research. 43(2). 100–105. 7 indexed citations

19.

Venugopal, V., Bharat Singh, Nandini Verma, et al.. (2007). Screening of Thermophiles From Municipal Solid Waste and Their Selective Antimicrobial Profile. 1(1). 17–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact